BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Celldex Therapeutics, Inc. 

222 Cameron Drive
Suite 400
Phillipsburg  New Jersey  08865  U.S.A.
Phone: 908-454-7120 Fax: 908-454-1911


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Celldex Therapeutics, Inc. (CLDX) Announces Appointment To Board Of Directors 12/18/2014 7:58:42 AM
Celldex Therapeutics, Inc. (CLDX) Announces Completion Of Enrollment In Phase 3 Study Of Rindopepimut In Frontline Glioblastoma 12/16/2014 7:37:02 AM
Celldex Therapeutics, Inc. (CLDX) Initiates A Phase 2 Study Of Glembatumumab Vedotin In Patients With Advanced Melanoma 12/5/2014 9:26:07 AM
Celldex Therapeutics, Inc. (CLDX) Release: Interim Update From Randomized Phase 2 ReACT Study Of Rindopepimut In Recurrent Bevacizumab-Naive Glioblastoma Demonstrates Statistically Significant Survival Benefit 11/17/2014 10:30:09 AM
Oncothyreon Inc. (ONTY) And Celldex Therapeutics, Inc. (CLDX) Announce Initiation Of Combination Immunotherapy Clinical Trial Of ONT-10 And Varlilumab 11/11/2014 7:33:42 AM
Celldex Therapeutics, Inc. (CLDX) Presents Varlilumab Proof Of Concept Data At SITC Annual Meeting 2014 11/7/2014 12:17:34 PM
Celldex Therapeutics, Inc. (CLDX) Reports Third Quarter 2014 Results 11/5/2014 7:43:06 AM
Celldex Therapeutics, Inc. (CLDX) Announces Upcoming Presentations of Rindopepimut Data at 19th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO) 11/3/2014 10:13:46 AM
Celldex Therapeutics, Inc. (CLDX) Announces Publication Of Glembatumumab Vedotin Phase 1/2 Studies In The Journal Of Clinical Oncology 9/30/2014 9:14:10 AM
Celldex Therapeutics, Inc. (CLDX) Initiates Pilot Study Of CDX-301 In Allogeneic Hematopoietic Stem Cell Transplantation 9/25/2014 8:25:28 AM
12345678910...